NDC 0363-4546

Walgreens Eye Drops Maximum Redness Relief 15mL

Glycerin, Naphazoline Hci

Walgreens Eye Drops Maximum Redness Relief 15mL is a Ophthalmic Liquid in the Human Otc Drug category. It is labeled and distributed by Walgreen Company. The primary component is Naphazoline Hydrochloride; Glycerin.

Product ID0363-4546_949d4a4d-b0f9-81f8-e053-2995a90a818d
NDC0363-4546
Product TypeHuman Otc Drug
Proprietary NameWalgreens Eye Drops Maximum Redness Relief 15mL
Generic NameGlycerin, Naphazoline Hci
Dosage FormLiquid
Route of AdministrationOPHTHALMIC
Marketing Start Date2019-10-10
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart349
Labeler NameWalgreen Company
Substance NameNAPHAZOLINE HYDROCHLORIDE; GLYCERIN
Active Ingredient Strength0 g/100mL; g/100mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0363-4546-01

1 BOTTLE, DROPPER in 1 BOX (0363-4546-01) > 15 mL in 1 BOTTLE, DROPPER
Marketing Start Date2019-10-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0363-4546-01 [00363454601]

Walgreens Eye Drops Maximum Redness Relief 15mL LIQUID
Marketing CategoryOTC monograph final
Application Numberpart349
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-10-10

Drug Details

Active Ingredients

IngredientStrength
NAPHAZOLINE HYDROCHLORIDE.03 g/100mL

OpenFDA Data

SPL SET ID:949d4a4d-b0f8-81f8-e053-2995a90a818d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1235200
  • UPC Code
  • 0311917200750
  • NDC Crossover Matching brand name "Walgreens Eye Drops Maximum Redness Relief 15mL" or generic name "Glycerin, Naphazoline Hci"

    NDCBrand NameGeneric Name
    0363-4546Walgreens Eye Drops Maximum Redness Relief 15mLGlycerin, Naphazoline HCI
    72476-012CareOne Maximum Redness Relief Eye DropsGlycerin, Naphazoline HCI
    41250-715Meijer Maximum Redness Relief and LubricantGlycerin, Naphazoline HCI
    41250-846Meijer Redness ReliefGlycerin, Naphazoline HCI
    0363-4548Walgreens Redness Relief Eye Drops 15mLGlycerin, Naphazoline HCI

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.